Trade Summary

5 days ago, SHERWIN STEPHEN A, serving as Dir at NEUROCRINE BIOSCIENCES INC (NBIX), sold 25,000 shares at $165.32 per share, for a total transaction value of $4,132,968.88. Following this transaction, SHERWIN STEPHEN A now holds 15,860 shares of NBIX.

This sale represents a 61.18% decrease in SHERWIN STEPHEN A's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, June 5, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 9, 2026 at 5:40 PM ET, 4 days after the trade was made.

NEUROCRINE BIOSCIENCES INC operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.